Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Director sold 26,685 shares at $122.55 ($3,270,169)
  3. 4 Planned sale See Remarks sold 30,955 shares at an average $125.58 ($3,887,320)
  4. 4 Planned sale Director sold 103,606 shares at an average $118.25 ($12,251,411)
  5. 4 Planned sale See Remarks sold 3,664 shares at $114.49 ($419,491)
  6. 4 Planned sale Director sold 10,000 shares at an average $111.43 ($1,114,261)
  7. 4 Open-market sale Chief Business Officer sold 10,000 shares at $116.26 ($1,162,572)
  8. 4 Gift Chief Business Officer gave 11,530 shares (gift)
  9. 4 Planned sale See Remarks sold 1,031 shares at $114.52 ($118,068)
  10. 4 Planned sale Chief Development Officer sold 16,300 shares at an average $113.43 ($1,848,890)
  11. 4 Planned sale Chief Development Officer sold 3,700 shares at $113.12 ($418,562)
  12. 4 Planned sale See Remarks sold 20,305 shares at $114.70 ($2,329,075)
  13. 4 Open-market sale See Remarks sold 1,540 shares at $114.16 ($175,806)
  14. 4 Planned sale Chief Financial Officer sold 80,000 shares at an average $114.71 ($9,177,109)
  15. 4 Planned sale Director sold 10,000 shares at an average $88.30 ($882,986)
  16. 4 Planned sale Chief Financial Officer sold 40,000 shares at an average $87.71 ($3,508,277)
  17. 4 Gift Chief Business Officer gave 600 shares (gift)
  18. 4 Planned sale Chief Development Officer sold 20,000 shares at an average $93.13 ($1,862,530)
  19. 4 Planned sale See Remarks sold 25,000 shares at an average $88.35 ($2,208,737)
  20. 4 Planned sale Director sold 10,000 shares at an average $83.20 ($832,049)

Page 2 of 60 · 1,196 filings